Home

Richard F Fitzgerald

CIK 1459933 · Chief Financial Officer · last filed 2022-03-23

Richard F Fitzgerald is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 5 companies since 2016. The most recent filing, for XXII, was dated Mar 23, 2022.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

12

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XXII Chief Financial Officer 0 $4.41 $0 $0 1 2022-03-23
IMNM Chief Financial Officer — $25.06 — $0 1 2020-10-05
Carisma Therapeutics Inc. (SESN) Delisted Chief Financial Officer — $12.58 — $0 1 2019-02-25
Carisma Therapeutics Inc. (EBIO) Delisted Chief Financial Officer — — — $0 2 2018-04-11
PAVmed Inc. (PAVM.U) Delisted CFO and Secretary 200 — — $0 3 2016-06-03

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-03-23 XXII Grant (A) +124,722 $0 EDGAR
2020-10-05 IMNM Grant (A) — $0 EDGAR
2019-02-25 Carisma Therapeutics Inc. (SESN) Delisted Grant (A) — $0 EDGAR
2018-04-11 Carisma Therapeutics Inc. (EBIO) Delisted Grant (A) — $0 EDGAR
2018-01-25 Carisma Therapeutics Inc. (EBIO) Delisted Grant (A) — $0 EDGAR
2016-06-03 PAVmed Inc. (PAVM.U) Delisted Mixed +200 $0 EDGAR
2016-05-27 PAVmed Inc. (PAVM.U) Delisted Mixed +100 $0 EDGAR
2016-05-02 PAVmed Inc. (PAVM.U) Delisted Grant (A) — $0 EDGAR
2015-09-14 — Tax (F) +67,500 $5.4K
2013-06-17 — Grant (A) — $0
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.